Cargando…

SLC14A1: a novel target for human urothelial cancer

Urinary bladder cancer is the second commonly diagnosed genitourinary malignancy. Previously, bio-molecular alterations have been observed within certain locations such as chromosome 9, retinoblastoma gene and fibroblast growth factor receptor-3. Solute carrier family 14 member 1 (SLC14A1) gene enco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, R., Kong, X., Yang, B., Xie, Y., Chen, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700210/ https://www.ncbi.nlm.nih.gov/pubmed/28589430 http://dx.doi.org/10.1007/s12094-017-1693-3

Ejemplares similares

SLC14A1 (UT-B) gene rearrangement in urothelial carcinoma of the bladder: a case report
por: Guo, Zhongying, et al.
Publicado: (2020)

SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma
por: Chan, Ti-Chun, et al.
Publicado: (2020)

Identification of a Novel UT-B Urea Transporter in Human Urothelial Cancer
por: Hou, Ruida, et al.
Publicado: (2017)

Study on the role of SLC14A1 gene in biochemical recurrence of prostate cancer
por: Ye, Bin, et al.
Publicado: (2022)

Human solute carrier SLC6A14 is the β-alanine carrier
por: Anderson, Catriona M H, et al.
Publicado: (2008)

Mitochondrial SLC25 Carriers: Novel Targets for Cancer Therapy
por: Rochette, Luc, et al.
Publicado: (2020)

Slc7a14 Is Indispensable in Zebrafish Retinas
por: Zhuang, You-Yuan, et al.
Publicado: (2019)

SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine–Glycine–One-Carbon Pathways in Cancer
por: Sniegowski, Tyler, et al.
Publicado: (2021)

Targeting cancer metabolism at the plasma membrane by limiting amino acid access through SLC6A14
por: McCracken, Alison N., et al.
Publicado: (2015)

Amino Acid Transporter SLC6A14 (ATB(0,+)) – A Target in Combined Anti-cancer Therapy
por: Nałęcz, Katarzyna A.
Publicado: (2020)

Novel Tyrosine Kinase Targets in Urothelial Carcinoma
por: Torres-Jiménez, Javier, et al.
Publicado: (2021)

HUS1 as a Potential Therapeutic Target in Urothelial Cancer
por: Lindner, Andrea Katharina, et al.
Publicado: (2022)

A novel homozygous SLC39A14 variant in an infant with hypermanganesemia and a review of the literature
por: Zhang, Meijiao, et al.
Publicado: (2023)

Decreased expression of SLC 39A14 is associated with tumor aggressiveness and biochemical recurrence of human prostate cancer
por: Xu, Xiao-Ming, et al.
Publicado: (2016)

Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression
por: Zhang, Yunwen, et al.
Publicado: (2023)

Discovery of a novel target for cancer: PRR14
por: Xiao, Shaowen, et al.
Publicado: (2016)

Alloferon Affects the Chemosensitivity of Pancreatic Cancer by Regulating the Expression of SLC6A14
por: Jo, Hyejung, et al.
Publicado: (2022)

SLC1A1, SLC16A9, and CNTN3 Are Potential Biomarkers for the Occurrence of Colorectal Cancer
por: Zhou, Jie, et al.
Publicado: (2020)

Correction: Brosch et al. Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell Migration. Cancers 2022, 14, 5794
por: Brosch, Philippa K., et al.
Publicado: (2023)

Unconventional Functions of Amino Acid Transporters: Role in Macropinocytosis (SLC38A5/SLC38A3) and Diet-Induced Obesity/Metabolic Syndrome (SLC6A19/SLC6A14/SLC6A6)
por: Bhutia, Yangzom D., et al.
Publicado: (2022)

SLC7A14 linked to autosomal recessive retinitis pigmentosa
por: Jin, Zi-Bing, et al.
Publicado: (2014)

Amplicon targeted resequencing for SLC2A9 and SLC22A12 identified novel mutations in hypouricemia subjects
por: Zhou, Zhaowei, et al.
Publicado: (2019)

A pan-cancer analysis of SLC1A5 in human cancers
por: Ni, Juan, et al.
Publicado: (2023)

Promoter methylation analysis of CDH1 and p14ARF genes in patients with urothelial bladder cancer
por: Bayramov, Bayram, et al.
Publicado: (2018)

TRIM6 Reduces Ferroptosis and Chemosensitivity by Targeting SLC1A5 in Lung Cancer
por: Zhang, Ying, et al.
Publicado: (2023)

Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma
por: Penheiter, Alan R., et al.
Publicado: (2015)

Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment
por: Nachef, Marianna, et al.
Publicado: (2021)

Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal Cancer
por: Lu, Ying, et al.
Publicado: (2022)

SLC12A5 interacts and enhances SOX18 activity to promote bladder urothelial carcinoma progression via upregulating MMP7
por: Wang, Long, et al.
Publicado: (2020)

Circ_000829 Plays an Anticancer Role in Renal Cell Carcinoma by Suppressing SRSF1-Mediated Alternative Splicing of SLC39A14
por: Feng, Jia-fu, et al.
Publicado: (2022)

Long Noncoding RNA, MicroRNA, Zn Transporter Zip14 (Slc39a14) and Inflammation in Mice
por: Jimenez-Rondan, Felix R., et al.
Publicado: (2022)

MicroRNA-147a Targets SLC40A1 to Induce Ferroptosis in Human Glioblastoma
por: Xu, Peng, et al.
Publicado: (2022)

Deletion of Slc26a1 and Slc26a7 Delays Enamel Mineralization in Mice
por: Yin, Kaifeng, et al.
Publicado: (2017)

Exploiting the metabolic dependencies of the broad amino acid transporter SLC6A14
por: Dejure, Francesca R., et al.
Publicado: (2020)

Loss of slc39a14 causes simultaneous manganese hypersensitivity and deficiency in zebrafish
por: Tuschl, Karin, et al.
Publicado: (2022)

Bladder Cancer and Urothelial Impairment: The Role of TRPV1 as Potential Drug Target
por: Mistretta, Francesco, et al.
Publicado: (2014)

Study of Three Single Nucleotide Polymorphisms in the SLC6A14 Gene in Association with Male Infertility
por: Noveski, P, et al.
Publicado: (2015)

Association of SLC22A1, SLC22A2, SLC47A1, and SLC47A2 Polymorphisms with Metformin Efficacy in Type 2 Diabetic Patients
por: Chen, Peixian, et al.
Publicado: (2022)

Antifungal immunity mediated by C-type lectin receptors may be a novel target in immunotherapy for urothelial bladder cancer
por: Li, Tianhang, et al.
Publicado: (2022)

Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 2022, 14, 5344
por: Zheng, Haosheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v4ve57rbvkubq0uf77ul8v72me